; (II) establish payment parameters for each covered part D drug that considers how the drug is dispensed and what pharmacy services are provided by each type of pharmacy to support drug management with the individual for whom the drug is dispensed; and (III) establish an appeal process in which the pharmacy may appeal payment, in writing and with supporting documentation, to the Medicare Pharmaceutical and Technology Ombudsman within 60 days following notification of the payment or any adjustment of such payment of such a drug, if a network pharmacy believes that the amount a PDP offering a prescription drug plan or an MA organization offering an MA–PD plan has paid for such drug is below the pharmacy’s lowest actual acquisition and dispensing costs of such drug. (vi) Utilization of pharmacy acquisition cost data With respect to the requirement under clause (v)(I) for the Secretary to utilize pharmacy acquisition cost data— (I) the Secretary shall utilize pharmacy acquisition cost data described in section 1927(f), relating to a survey of retail prices; and (II) for each covered part D drug not included in the survey described in section 1927(f), the Secretary shall amend the survey or establish a survey. . 3. Ensuring fair assessment of pharmacy performance and quality Section 1860D–2(d) of the Social Security Act ( 42 U.S.C. 1395w–102(d) ) is amended— (1) in paragraph (1)(B), by striking For purposes and inserting Subject to paragraph (4), for purposes